Bausch Lomb introduced a new hydrogel-based contact lens, in early 2022, which is a one-day disposable type of contact lens.

Comfort was the name of the game when OT spoke with contact lens manufacturers and suppliers about recent trends and launches ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...

Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

With Bausch + Lomb ULTRA ONE DAY contact lenses, eye care professionals can offer a solution that stands up to real-life ...

Partnership Creates New Opportunities to Address Unmet Needs Related to Posterior Segment Eye Diseases in China - ...

The global body contouring treatments market growth forecasted to transform from USD 1.46 billion in 2024 to USD 2.58 billion ...

Bausch + Lomb Corporation (NYSE: BLCO) announced on November 1, 2024, that they have entered into the Second Incremental Amendment to their existing credit and guaranty agreement. The amendment, known ...

Trustee Chris Bausch asks a question during a Paso Robles Joint Unified School District Board meeting on June 22, 2021, regarding a resolution to ban teaching of critical race theory at its schools.

Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...

Bausch + Lomb (NYSE:BLCO – Get Free Report)‘s stock had its “hold” rating reaffirmed by research analysts at Needham & ...

The company reports revenues under five segments — Salix, International, Diversified Products, Solta Medical and Bausch + Lomb. Salix revenues totaled $642 million, up 5% year over year.